You are here

Industry News

Advamed Smart Brief

July 24, 2017
Siemens Healthineers has agreed to pay an undisclosed amount for Alere's point-of-care blood diagnostics subsidiary, Epocal.  -More
July 24, 2017
UK-based regenerative medicine firm Tissue Regenix reached a deal to acquire its San Antonio-based competitor CellRight Techn -More
July 24, 2017
The second tranche of Titan Medical's public offering of shares has pulled in $1.3 million, bringing the offering's total pro -More
July 24, 2017
An offering of convertible promissory notes and Series C preferred stock warrants brought in an additional $6 million for Map -More
July 24, 2017
A round of financing pulled in $6.6 million for Winter Park, Fla.-based Genicon, which makes devices for laparoscopic surgery -More
July 24, 2017
Pops! Diabetes Care said the first patient in a trial of its Pops!  -More
July 24, 2017
The World Health Organization granted OraSure Technologies prequalification for its OraQuick HIV Self-Test, a product that de -More
July 24, 2017
Comments have been submitted by AdvaMed and other stakeholders about the CMS' national coverage analysis for implantable card -More
July 24, 2017
A draft guidance was released by the Indian government under its impending Medical Devices Rules, set to take effect next yea -More
July 24, 2017
A recall initiated by Penumbra involving 155 units of its Penumbra 3D Revascularization device, designed for acute ischemic s -More

Industry News

PR Newswire
Bio2 Medical today announced the results of the Angel® Catheter pivotal study, "Evaluation of a Device Combining an Inferior Vena Cava Filter and a Central Venous Catheter for Preventing Pulmonary Embolism Among Critically Ill Trauma Patients," published in the Journal of Vascular and Interventional Radiology (JVIR).  The Angel® Catheter met all safety endpoints and demonstrated a significant reduction in clinically significant and fatal pulmonary embolism (PE). The novel device was tested in a...
RealClear Health
Often undiagnosed, an estimated two to six million people in the United States have a serious heart condition called atrial fibrillation, or AFib. As those living with the disease know, complications from the irregular heartbeat caused by the AFib can be potentially devastating: The average person with AFib is five times more likely to suffer a stroke than someone with a regular heartbeat. Fortunately, there is innovative medical technology available today poised to make a real difference in...
Legal Backgrounder
When a doctor implants a medical device, he or she often requests the presence of a representative of the device manufacturer (a “rep”) in the operating room. Some observers are critical of this practice, demanding thatreps be barred from the O.R. At the same time,some lawyersthink repsin the O.R.should be subject to liability in the court system. This Legal Backgrounder explains why reps often play an important, if limited, role in the O.R., and why that role should not expose reps to lawsuits
Business Wire
ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced today the closing of a $36 million Series C financing, including existing convertible notes. The round was led by Philips and UPMC, through its innovation and commercialization arm UPMC Enterprises, with other new and existing investors participating. The funding will support a planned US-based pivotal trial for...
Washington Examiner
Imagine for a moment that you are one of the approximately 44 million women in the U.S. affected by cardiovascular disease, or one of the 24 million with osteoarthritis. You'd want access to the most advanced and effective care. Oftentimes, your doctor would recommend a medical technology or device as an essential component of your treatment – placing a stent in a blocked artery or replacing your knee or hip with a new artificial one, for example. ​​​​​​